T1000	Negation 699 702	not
E1000	Negation:T1000 Scope:T1001
T1001	Span 660 850	The 32,000-Mr form of oncostatin M was not produced by cells transfected with plasmids (G195 and G196) in which a potential trypsinlike cleavage site within the hydrophilic C-terminal domain
T1002	Negation 500 506	lacked
E1001	Negation:T1002 Scope:T1003
T1003	Span 500 581	lacked a hydrophilic C-terminal domain comprising predominantly basic amino acids
T1004	Speculation 1006 1013	suggest
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1006 1186	suggest that the 32,000-Mr form of oncostatin M was derived from the 227-amino-acid propeptide by proteolytic cleavage at or near the paired basic residues at positions 195 and 196
T1006	Speculation 774 783	potential
E1003	Speculation:T1006 Scope:T1007
T1007	Span 774 891	potential trypsinlike cleavage site within the hydrophilic C-terminal domain was altered by site-directed mutagenesis
T1008	Negation 1597 1600	not
E1004	Negation:T1008 Scope:T1009
T1009	Span 1537 1660	the highly charged C-terminal domain of pro-oncostatin M is not required for receptor binding or growth-inhibitory activity
T1010	Speculation 1128 1130	or
E1005	Speculation:T1010 Scope:T1011
T1011	Span 1128 1186	or near the paired basic residues at positions 195 and 196
T1012	Speculation 1756 1759	may
E1006	Speculation:T1012 Scope:T1013
T1013	Span 1756 1823	may be important for regulating in vivo activities of this cytokine
T1014	Speculation 1665 1668	may
E1007	Speculation:T1014 Scope:T1015
T1015	Span 1665 1716	may alter the functional properties of the molecule
